@article{798282b57e6847ab825be18c356869df,
title = "Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies",
author = "Giles, {F. J.} and N. Vey and D. Rizzieri and F. Ravandi and T. Prebet and G. Borthakur and Jacobsen, {T. F.} and S. Hagen and B. Nilsson and S. O'Brien",
note = "Funding Information: This study was supported by the Canadian Institutes of Health Research (CIHR) and the Leukemia and Lymphoma Society of Canada (to DS) and a QEII-SST graduate scholarship from the University of Toronto (to ST). Funding Information: FJ Giles, N Vey, D Rizzieri and S O{\textquoteright}Brien have received research funding from Clavis Pharma. TF Jacobsen, S Hagen and B Nilsson are/were Clavis Pharma employees. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2012",
month = jul,
doi = "10.1038/leu.2012.1",
language = "English (US)",
volume = "26",
pages = "1686--1689",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",
}